SAN DIEGO--(BUSINESS WIRE)--Somaxon Pharmaceuticals, Inc. (Nasdaq:SOMX), a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology, today announced the appointments of Daniel Schneider to the newly-created position of Vice President of Sales and Joseph Merkert to the newly-created position of Vice President of Sales Operations and Managed Care.
